Samsung focuses on the early detection of Alzheimer's symptoms through digital biomarkers!

Calendar 9/26/2025

Samsung uses smartphones and Galaxy Watch to detect Alzheimer’s early. Digital biomarkers could change diagnostics worldwide.

Alzheimer's disease is currently the most common cause of dementia in the world, accounting for 60-70% of cases. Year after year, the problem grows with the aging of populations. It becomes crucial not only to treat but, above all, to detect subtle symptoms as early as possible. And this is where Samsung comes in, as it is genuinely changing the approach to diagnostics with its digital biomarker technology.

Smartphones and Wearables as Medical Tools

Samsung Research has developed a solution that turns our everyday devices – Galaxy smartphones and Galaxy Watch smartwatches – into unique "health sensors." By analyzing user behaviors, such as typing patterns, conversation pace, sleep patterns, and even walking parameters, the system can detect early signs of cognitive disorders.

These are not theoretical considerations – research shows that the effectiveness of this method matches that of traditional hospital screening tests. Importantly, the analysis occurs with minimal intrusion on privacy, as the system does not examine content, only non-verbal parameters.

Impact on Diagnosis and Care

Samsung is not limited to just collecting data. The developed algorithms allow for a realistic assessment of the user's cognitive condition and monitor its changes over time. As a result:

  • doctors can respond more quickly and refer patients for further testing,

  • patients gain the opportunity for early intervention – from lifestyle changes to participation in new therapies,

  • the healthcare system receives a tool that can alleviate the burden on hospitals and improve diagnostic effectiveness on a mass scale.

Technology with a Mission

What distinguishes Samsung is the vision that everyday devices become support for medicine. The Samsung Research team does not view smartphones or watches solely as consumer devices, but as a bridge connecting daily life with healthcare.

Digital biomarkers are not just technology – they are a promise to improve the quality of life for millions of people who could live independently for years if diseases were detected earlier.

Katarzyna Petru Avatar
Katarzyna Petru

Journalist, reviewer, and columnist for the "ChooseTV" portal